BWAY
BrainsWay Ltd.NASDAQHealthcare$13.57-7.30%ClosedMarket Cap: $532.3M
As of 2026-04-06
Valuation
P/E (TTM)
69.56
PEG
0.43
P/B
7.08
P/S
9.62
EV/EBITDA
76.04
DCF Value
$-6.20
FCF Yield
3.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.4%
Operating Margin
8.3%
Net Margin
14.6%
ROE
12.0%
ROA
7.3%
ROIC
5.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $14.6M | 76.4% | $1.9M | $3.0M | $0.14 | — |
| FY 2025 | $52.6M | 75.4% | $4.4M | $7.7M | $0.36 | — |
| Q3 2025 | $13.5M | 75.2% | $1.3M | $1.6M | $0.04 | — |
| Q2 2025 | $12.6M | 75.2% | $578.0K | $2.0M | $0.05 | — |
| Q1 2025 | $11.5M | 74.6% | $576.0K | $1.1M | $0.02 | — |
| Q4 2024 | $11.4M | 74.6% | $431.0K | $1.5M | $0.04 | — |
| FY 2024 | $41.0M | 74.6% | $1.4M | $2.9M | $0.09 | — |
| Q3 2024 | $10.5M | 73.5% | $281.0K | $662.0K | $0.04 | — |
| Q2 2024 | $10.0M | 75.3% | $586.0K | $600.0K | $0.02 | — |
| Q1 2024 | $9.1M | 74.9% | $93.0K | $111.0K | $0.00 | — |
| Q4 2023 | $9.0M | 74.6% | $10.1M | $127.0K | $0.00 | — |
| FY 2023 | $31.8M | 73.9% | $-5.0M | $-4.2M | $-0.13 | — |